case | gender | age | PD duration | H&Y stage | concurrent medication | DA-LED | TLED | ICD behaviors |
---|---|---|---|---|---|---|---|---|
1 | M | 75 | 6 | 3 | L-DA+ pra | 200 | 1100 | PG |
2 | M | 67 | 4 | 2 | L-DA | 0 | 300 | PG |
3 | M | 69 | 3 | 2 | L-DA+ pra | 150 | 450 | HS |
4 | F | 62 | 5 | 1 | L-DA+ pra | 150 | 825 | CS |
5 | M | 49 | 8 | 3 | L-DA+ pra | 225 | 3000 | HS |
6 | M | 50 | 5 | 3 | L-DA+ pra | 200 | 500 | HS |
7 | F | 73 | 10 | 3 | L-DA | 0 | 600 | BE |
8 | F | 51 | 4 | 2 | L-DA + pir | 100 | 300 | PG |
9 | M | 68 | 10 | 3 | L-DA + pir + ent | 50 | 1014.25 | HS |